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AbstrAct
Transcatheter aortic valve replacement (TAVR) has become 
the preferred therapy for treatment of severe aortic stenosis in 
patients at intermediate to high risk of perioperative mortality 
following surgical aortic valve replacement. Haemodynamic 
assessment is an integral part of the procedure, and it is 
crucial for the operator to have an in-depth understanding 
of the haemodynamic alterations that occur during balloon 
aortic valvuloplasty and transcatheter valve deployment. 
Comprehension of the haemodynamic tracings is also 
pivotal for early recognition of periprocedural complications. 
With expanding indications for TAVR, it is imperative for 
members of the structural heart team to have an in-depth, 
nuanced understanding of transcatheter haemodynamic 
waveforms and their correlation with echocardiographic 
Doppler waveforms that are obtained periprocedurally during 
TAVR. This review provides a collection of transcatheter 
haemodynamic tracings and their corresponding Doppler 
echocardiography correlates that are demonstrative 
of physiological alterations and pathological lesions 
(complications) that occur during TAVR.
IntroduCtIon
Transcatheter aortic valve replacement (TAVR) 
has become the preferred therapy for treatment 
of severe aortic stenosis in patients at interme-
diate to high risk of perioperative mortality 
following surgical aortic valve replacement.1 The 
technology has witnessed an exponential adop-
tion rate among operators and is expanding 
to many hospitals across the USA.2Haemod-
ynamic assessment is an integral part of the 
procedure, and it is crucial for the operator to 
have an in-depth understanding of the haemo-
dynamic alterations that occur during balloon 
aortic valvuloplasty and transcatheter valve 
deployment. Comprehension of the haemod-
ynamic tracings is also pivotal for early recog-
nition of periprocedural complications. Early 
recognition of haemodynamic alterations facil-
itates rapid decision-making in a chronolog-
ical, stepwise fashion for a successful outcome. 
This review provides a collection of transcath-
eter haemodynamic tracings and their corre-
sponding Doppler echocardiography corre-
lates that are demonstrative of physiological 
alterations and pathological lesions (complica-
tions) that occur during TAVR.
Case vignette #1: transcatheter and doppler 
waveforms in severe aortic stenosis, pre-
transcatheter and post-transcatheter aortic valve 
replacement
Learning objective
Recognition of classic transcatheter haemodynamic 
waveforms of the stenotic valve is critical prior to 
proceeding with TAVR.
The classical haemodynamic findings of 
severe aortic stenosis are demonstrated in 
figure 1—aortic (Ao and left ventricular 
(LV) pressures obtained from intraproce-
dural transcatheter tracings (panel (i)) and 
correlating echocardiographic Doppler 
waveforms obtained from periprocedural 
transthoracic echocardiograms (panels 
(ii–iv)) before (pre, panel A) and after 
TAVR (post, panel B) are shown. Before 
TAVR, the large LV–Ao gradient, the slow 
aortic pressure upstroke (pulsus tardus et 
parvus; solid red line) and absence of an 
anacrotic shoulder and dicrotic notch are 
evident (panel A(i)). After TAVR (right), 
there is complete resolution of peak instan-
taneous gradient and peak–peak gradient 
with recovery of brisk aortic upstroke (solid 
green line). Both the anacrotic shoulder 
and dicrotic notch of aortic valve closure 
have returned (panel B(i)). Corresponding 
continuous-wave (CW) Doppler wave-
forms in panel (iv) demonstrate a signif-
icant reduction in transaortic gradients 
post TAVR.
Case vignette #2: mixed aortic stenosis and 
regurgitation before and after tAVr
Learning objective
In this vignette, transcatheter haemodynamic find-
ings associated with mixed aortic stenosis and 
regurgitation are reviewed.
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Figure 2, panel A(i), demonstrates a large LV–Ao 
gradient and an increased pulse pressure, especially 
evident following a ventricular ectopic (VE) beat in 
severe aortic stenosis. Panel A also demonstrates severe 
aortic regurgitation, suggested by low aortic diastolic 
pressure, wide pulse pressure and low Ao diastolic–LV 
end-diastolic pressure (LVEDP) gradient. This lesion 
is confirmed on a transoesophageal echocardiogram 
(TEE) (panel A(ii)). As demonstrated in figure 1, 
amelioration of aortic stenosis following TAVR is 
shown by resolution of LV–Ao gradients, brisk arterial 
upstroke (solid green line) and return of the dicrotic 
notch following TAVR (panel B). The increased aortic 
diastolic pressure and Ao diastolic–LVEDP gradient, 
and the presence of a dicrotic notch suggest amelio-
ration of aortic regurgitation, which is clearly demon-
strable on TEE (panel B(ii)). Despite no evidence 
of significant aortic regurgitation post TAVR, there 
is a persistent wide pulse pressure. A rise in LVEDP 
is noted, which is likely due to increased heart rate 
and blood pressure, compared with that due to aortic 
regurgitation or perivalvular leak.
Figure 1 The systolic ejection period (SEP) in panel (i), 
from the end of isovolumic contraction to the beginning of 
ventricular diastole, corresponds to the ejection time (ET) in 
panel (iv). The duration of the aortic upstroke (solid red and 
green lines in panel (i)) corresponds to the acceleration time 
(AT) in panel (iv). The diastolic filling period (DFP) in panel (i), 
from aortic valve closure to mitral valve closure, corresponds 
to the period between the start of the E wave (early passive 
filling) to the end of the A wave (atrial contraction) of the 
mitral inflow Doppler waveforms in panel (ii). The p wave 
of the ECG corresponds to the A wave in panel (ii), while 
the R wave corresponds to the onset of ventricular systole, 
which occurs on mitral valve closure (blue dashed line). 
Panel (ii): pulse-wave (PW) Doppler at the tip of the mitral 
leaflets; panel (iii): PW Doppler in the left ventricular outflow 
tract; panel (iv): CW Doppler across the aortic valve. AVC, 
aortic valve closure; AVO, aortic valve opening;  MVC, mitral 
valve closure; MVO, mitral valve opening; PCWP, pulmonary 
capillary wedge pressure; TAVR, transcatheter aortic valve 
replacement.
Figure 2 Ao, aorta; CF, color-flow; LV, left ventricle; LV EDP, 
left ventricular end-diastolic pressure; SBP, systolic blood 
pressure; TAVI, transcatheter aortic valve implantation; VE, 
ventricular ectopic.
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Case vignette #3: pressure recovery, and mixed aortic 
stenosis and regurgitation
Learning objective
In severe aortic stenosis, maximal transvalvular gradient is 
recorded at the level of the vena contracta.3 This measurement 
is difficult to obtain accurately by cardiac catheterisation as it is 
cumbersome to position and maintain the pressure transducer at 
the level of the vena contracta. Cardiac catheterisation measures 
transvalvular pressure downstream to the vena contracta, where 
part of the jet kinetic energy is recovered.3 This pressure recovery 
(maximal transvalvular gradient—net transvalvular gradient) 
results in a lower transvalvular gradient compared with maximal 
transvalvular gradient measured by Doppler echocardiography. 
Pressure recovery is dependent on the valve effective orifice area 
and aortic cross-sectional area.3This vignette demonstrates the 
phenomenon of pressure recovery in severe aortic stenosis.
Figure 3 demonstrates the phenomenon of pressure 
recovery in severe aortic stenosis (panels A (auto-phase 
correction ‘on’) and B (auto-phase correction ‘off’))—si-
multaneous femoral artery (Fem) waveforms are higher 
than aortic (Ao) waveforms recorded just distal to the 
stenosed aortic valve. Pressure recovery is more common 
in patients with small aortas, as demonstrated on cardiac 
CT scan (panel C). Panels D (pre-TAVR) and E (post-
TAVR) show transcatheter waveforms (panel (i)) and 
color-flow Doppler TEE images (panel (ii)) of the aortic 
valve in long and short axes. There is severe mixed aortic 
stenosis and regurgitation, which is ameliorated following 
TAVR (panel E). A ‘reverse’ LV-femoral arterial gradient 
in panel E is attributable to pressure recovery.
The following three case vignettes describe peri-TAVR aortic 
regurgitation (central and paravalvular) that occur immediately 
following deployment of the transcatheter valve. As demonstrated 
by these cases, accurate interpretation of the haemodynamic 
waveforms is key in making the correct diagnosis, and subse-
quent clinical decision-making and management.
Case vignette #4: perivalvular aortic regurgitation and its 
response to temporary pacing after tAVr
Learning objective
Identification of acute severe aortic insufficiency after TAVR, 
and its response to temporary pacing.
The management of severe regurgitation after TAVR 
presents only a few limited options. Depending on the 
proximate cause, one can dilate the valve to achieve 
optimal expansion and contact between the prosthesis 
and aortic annulus, use a perivalvular plug, implant 
another valve (valve-in-valve) or use pacing at rates of 
75–85 beats/min to decrease the diastolic time interval 
and hope for a reduction in aortic regurgitation as self-ex-
panding valves expand or as tissue ingrowth occurs into 
valve skirts. Figure 4 demonstrates transcatheter haemod-
ynamics before (panel A(i)) and after (panel A(ii)) TAVR 
(with heart block-related bradycardia). There is signifi-
cant aortic regurgitation immediately following TAVR. 
Within minutes following right ventricular pacing (panel 
C(iii)), aortic regurgitation is reduced with resolution of 
rapid filling over diastasis, increased diastolic pressure 
and end-diastolic LV–Ao gradient, and drop in LVEDP 
demonstrating the reduction in significant aortic regurgi-
tation. Peri-TAVR color-flow Doppler in the long-axis and 
short-axis views (panels B and C, respectively), and PW 
Doppler (panel D) echocardiography, all demonstrate 
varying degrees of aortic regurgitation following rapid 
right ventricular pacing.
Case vignette #5: severe aortic regurgitation following tAVr 
for low-flow, low-gradient aortic stenosis
Learning objective
Identification of acute severe aortic insufficiency after TAVR and 
understanding the different mechanisms of aortic insufficiency 
post TAVR.
In patients with reduced LV ejection fraction and low 
transaortic gradient, dobutamine stress echocardiog-
raphy can be used to confirm the presence of severe 
aortic stenosis (panels A(i)–A(iii)), further demon-
strated by transcatheter (B) and color-flow Doppler 
assessment (C) before TAVR (i) (figure 5). Immedi-
ately after TAVR (ii), severe central aortic regurgita-
tion was observed with characteristic haemodynamic 
waveforms showing near matching of LV and aortic 
pressure with equilibration over diastole, resulting 
in end-diastolic pressure matching. The severe aortic 
regurgitation was treated with placement of a second 
valve prosthesis (valve-in-valve TAVR) (iii), reducing 
aortic regurgitation to trivial central aortic regurgita-
tion and restoring optimal haemodynamic function 
with a low LV outflow tract (LVOT) gradient on CW 
Doppler (panel E(iii)). There is evidence of native 
Figure 3 Ao, aorta; CF, color-flow; Fem, femoral artery; LV, 
left ventricle; TAVR, transcatheter aortic valve replacement.
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left coronary leaflet overhang seen posteriorly (C(ii), 
asterisk, right panel, on the long-axis view), although 
aortic regurgitation appears to originate from failure of 
closure of the bioprosthetic anterior leaflet (C(i), left 
panel, short-axis view). Supporting evidence from tran-
scatheter haemodynamics (panel B(ii)) of severe aortic 
regurgitation immediately post TAVR is the significant 
diastolic flow reversal seen using CW Doppler of the 
descending aorta (panel D(i)), which is ameliorated 
after valve-in-valve TAVR (panel D(ii)). An accurate 
assessment of post-TAVR corrected effective orifice area 
(CEOA) includes PW Doppler sampling (yellow squares 
in far-right panels) in the LVOT before (panel E(i)) 
rather than after (panel E(ii)) flow convergence, and 
Figure 4 Ao, aorta; AR, aortic regurgitation; CFD, color-flow Doppler; LV, left ventricle; LV EDP, left ventricular end-diastolic 
pressure; PW, pulse-wave; TAVR, transcatheter aortic valve replacement.
Figure 5 Ao, aorta; CEOA, corrected effective orifice area; CFD, color-flow Doppler; CW, continuous-wave; DBP, diastolic 
blood pressure; LV EDP, left ventricular end-diastolic pressure; PW, pulse-wave; SBP, systolic blood pressure; TAVR, 
transcatheter aortic valve replacement; v-in-v, valve-in-valve.
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CW Doppler sampling (panel E(iii)) perpendicular to 
flow (yellow rectangle in far-right panel). The vignette 
depicts one of the mechanisms of aortic regurgitation 
post TAVR (central aortic regurgitation). Different 
mechanisms of aortic regurgitation post TAVR include 
prosthesis failure or misplacement (too low or too 
high), or annular calcification not allowing good valve 
skirt apposition.4
Case vignette #6: paravalvular aortic regurgitation following 
tAVr
Learning objective
Transcatheter and Doppler waveform correlation for accurate 
recognition of severity of post-TAVR aortic regurgitation.
Given the calcific and slit-like orifice of many aortic 
valves, and the configuration and distortion of the aortic 
orifice after balloon valvuloplasty, it is not unexpected 
that the circular stented valve would not be able to seal 
all the perivalvular crevices associated with perivalvular 
leaks.  Figure 6 demonstrates transcatheter haemo-
dynamics before (panel A(i)) and after (panel A(ii)) 
TAVR. The post-TAVR haemodynamics are consistent 
with moderate rather than severe aortic regurgi-
tation. Color-flow Doppler in short-axis view after 
TAVR (panel B) demonstrates paraprosthetic aortic 
regurgitation, with the circumferential extent >20%, 
suggestive of severe aortic insufficiency (by American 
Society of Echocardiography/Valve Academic Research 
Consortium criteria). However, a CW Doppler in the 
descending aorta post TAVR (panel C) with little dias-
tolic flow reversal is supportive of only mild aortic 
regurgitation. Presence of any degree of periprosthetic 
aortic regurgitation has been independently associ-
ated with mortality risk at 1 year.5 Calculation of the 
aortic regurgitation index (ratio of gradient between 
diastolic blood pressure and LVEDP to systolic blood 
pressure) provides a powerful prognostic assessment 
of the severity of aortic regurgitation.6 In a study of 
146 patients undergoing TAVR with self-expanding 
CoreValve (Medtronic, Minneapolis, Minnesota, USA), 
aortic regurgitation index <25 independently predicted 
1-year mortality, compared with an index >25 (46.0% vs 
16.7%; P<0.001; HR 2.9, 95% CI 1.3 to 6.4; P=0.009).6 
When there is discrepancy with regard to the severity of 
aortic regurgitation, aortic root angiography should be 
performed to assess for its severity, and balloon postdi-
lation to expand fully the aortic prosthesis should be 
strongly considered if there is more than mild residual 
periprosthetic aortic regurgitation. Balloon postdila-
tion for management of paravalvular leak post TAVR 
portends a risk of annular rupture. The decision to 
postdilate should be carefully weighed against the risk 
of rupture, taking into consideration the presence of 
bulging nodules of calcium and overall degree of calci-
fication of the annulus and outflow tract.7
The following two case vignettes describe peri-TAVR mitral 
valve lesions that occur immediately following deployment of 
the transcatheter valve. As demonstrated by these cases, accurate 
interpretation of the haemodynamic waveforms is key in making 
the correct diagnosis, and subsequent clinical decision-making 
and management.
Case vignette #7: mitral regurgitation following tAVr
Mechanisms of mitral regurgitation following TAVR 
include stent interference with the mitral leaflets, cath-
eter/wire disruption of the mitral valve apparatus or 
acute LV dilation with papillary muscle dysfunction. 
This vignette demonstrates changes in severity of mitral 
regurgitation with fluctuation in systemic blood pres-
sure prior to and following vasopressor administra-
tion. Figure 7 demonstrates CW Doppler waveforms 
Figure 6 Ao, aorta; AR, aortic regurgitation; CFD, color-
flow Doppler; LV, left ventricle; LV EDP, left ventricular end-
diastolic pressure; PW, pulse-wave; SBP, systolic blood 
pressure; TAVR, transcatheter aortic valve replacement.
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with (panel A(i)) and without (panel A(ii)) echocar-
diographic contrast agent use, and a short-axis TEE 
(panel C(i)) confirming severe aortic stenosis. There is 
a precipitous drop in blood pressure immediately after 
valve implantation (likely due to rapid pacing during 
valve deployment) (panel B(ii)) that responds appro-
priately to vasopressor administration (panel B(iii))—
note the change in the upstroke of LV end-diastolic 
pressure tracing following pressor administration. The 
TEE demonstrates severe mitral regurgitation during 
vasopressor administration (panel D(ii)) that resolves 
at the end of the procedure with gradual normalisa-
tion of blood pressure, and termination of vasopressor 
support (panels B(iv)–(v) and D(iii)).
Case vignette #8: mitral regurgitation following tAVr due to 
systolic anterior motion of the anterior mitral leaflet
Learning objective
Recognition of systolic anterior motion of the anterior mitral 
leaflet, and its appropriate management post TAVR.
Figure 8 demonstrates transcatheter haemodynamic 
findings pre TAVR (panel A(i)) and post TAVR (panel 
A(ii)). Color-flow Doppler echocardiographic findings 
at baseline (panel B), post TAVR (panel C), and at the 
end of the procedure (panel D), in systole (panel (i)) 
and diastole (panel (ii)) demonstrate increased contrac-
tility of a bulky interventricular septum following relief 
of aortic stenosis post TAVR, leading to systolic anterior 
motion of the anterior mitral leaflet (green arrow in 
panel C(i)). Severe mitral regurgitation due to systolic 
anterior motion of the anterior mitral leaflet responds 
appropriately to increased preload (fluid-loading) 
(panel D(i)). Anatomic risk factors for this compli-
cation include severe LV hypertrophy or a sigmoid 
septum that can be identified on preprocedure echo-
cardiogram or CT scan. However, not all cases respond 
to increased preload and may require alcohol septal 
ablation.8
The following two case vignettes highlight associated diastolic 
dysfunction that occurs in patients with severe aortic stenosis, 
and discrepancies in transcatheter and Doppler waveforms for 
peri-TAVR assessment of diastolic function.
Case vignette #9: diastolic dysfunction in tAVr
Patients with aortic stenosis have LV hypertrophy and 
diastolic dysfunction, often overshadowed by the severity 
of the LVOT obstruction. Once the outflow obstruc-
tion is relieved, the diastolic dysfunction can become 
manifest and unmasked for all to see. Figure 9 demon-
strates transcatheter (A) and transmitral Doppler (B) 
assessment of diastolic function before (i) and after 
(ii) TAVR. Before TAVR, the LV diastolic waveform 
has a normal-appearing filling pattern with LVEDP of 
20 mm Hg. After TAVR, there is an elevated plateau of 
diastolic pressure with a new appearance of an early dip 
consistent with a restrictive filling pattern (panel A(ii)). 
Scrutiny of the transmitral Doppler, pre TAVR (panel 
B(i)) and post TAVR (panel (ii)) shows no change from 
baseline evaluation with high E/A ratios pre TAVR and 
post TAVR.
Figure 7 Ao, aorta; CFD, color-flow Doppler; CW, continuous-wave; LV, left ventricle; LV EDP, left ventricular end-diastolic 
pressure; SBP, systolic blood pressure; TAVR, transcatheter aortic valve replacement.
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Case vignette #10; peri-tAVr diastolic dysfunction and aortic 
regurgitation after temporary pacing
Learning objective
Assessment of peri-TAVR diastolic function and its differentia-
tion from aortic regurgitation.
Various degrees of diastolic dysfunction and aortic 
regurgitation can occur after TAVR, which can be 
addressed by temporary pacing. Figure 10 demon-
strates transcatheter haemodynamics (panel A) and 
color-flow Doppler echocardiography in long-axis views 
(panel B) pre TAVR (panel (i)) and post TAVR (panel 
(ii)). Transcatheter (panel A(i)) and Doppler echocar-
diography (panel B(i)) findings before TAVR are both 
suggestive of moderate–severe aortic regurgitation. 
Despite mild aortic regurgitation after TAVR as seen on 
color-flow Doppler echocardiography (panel B(ii)) and 
confirmed by the absence of significant flow reversal 
(panel C), the haemodynamics after TAVR (panel 
A(ii)) are of moderate–severe aortic regurgitation 
with a low diastolic pressure and end-diastolic LV–Ao 
gradient, although there is a lack of rise in LV end-dias-
tolic pressure. Incremental right ventricular pacing rate 
Figure 9 Ao, aorta; LV, left ventricle; PW, pulse-wave; SBP, 
systolic blood pressure; TAVR, transcatheter aortic valve 
replacement.
Figure 10 Ao, aorta; ET, ejection time; LV, left ventricle; PW, 
pulse-wave; TAVR, transcatheter aortic valve replacement.
Figure 8 Ao, aorta; LV, left ventricle; LV EDP, left ventricular 
end-diastolic pressure; TAVR, transcatheter aortic valve 
replacement.
Open Heart
8 Kalra A, et al. Open Heart 2018;5:e000728. doi:10.1136/openhrt-2017-000728
(panel A(iii)–(v)) shortens the ejection time (ET) and 
increases the aortic diastolic pressure without changing 
the LV end-diastolic pressure. Pacing permits stabilisa-
tion and time to consider aetiologies and management 
options.
ConClusIon
With expanding indications for TAVR leading to a 
burgeoning TAVR-eligible population and an increase 
in structural heart programmes nationally, it is imper-
ative for members of the structural heart team (inter-
ventionalists and interventional echocardiographers) 
to have an in-depth, nuanced understanding of tran-
scatheter haemodynamic waveforms and their correla-
tion with echocardiographic Doppler waveforms that 
are obtained periprocedurally during TAVR. As demon-
strated by the case vignettes, accurate and timely inter-
pretation of transcatheter haemodynamic waveforms 
is the fulcrum on which the successful management of 
peri-TAVR haemodynamic alterations and complica-
tions is balanced. Moreover, a nuanced interpretation 
of transcatheter haemodynamic waveforms reinforces 
the appreciation of the physiological and engineering 
marvel of the human heart.
Competing interests DLB: Advisory Board: Cardax, Elsevier Practice Update 
Cardiology, Medscape Cardiology, Regado Biosciences; Board of Directors: Boston 
VA Research Institute, Society of Cardiovascular Patient Care; Chair: American Heart 
Association Quality Oversight Committee; Data Monitoring Committees:Cleveland 
Clinic, Duke Clinical Research Institute, Harvard Clinical Research Institute 
(including for serving as DMC Chair for the PORTICO trial funded by St. Jude, 
now Abbott), Mayo Clinic, Mount Sinai School of Medicine, Population Health 
Research Institute; Honoraria: American College of Cardiology (Senior Associate 
Editor, Clinical Trials and News,  ACC. org), Belvoir Publications (Editor in Chief, 
Harvard Heart Letter), Duke Clinical Research Institute (clinical trial steering 
committees), Harvard Clinical Research Institute (clinical trial steering committee), 
HMP Communications (Editor in Chief, Journal of Invasive Cardiology), Journal of 
the American College of Cardiology (Guest Editor; Associate Editor), Population 
Health Research Institute (clinical trial steering committee), Slack Publications 
(Chief Medical Editor, Cardiology Today’s Intervention), Society of Cardiovascular 
Patient Care (Secretary/Treasurer), Web MD (CME steering committees); Other: 
Clinical Cardiology (Deputy Editor), NCDR-ACTION Registry Steering Committee 
(Chair), VA CART Research and Publications Committee(Chair); Research Funding: 
Amarin, Amgen, Astra Zeneca, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest 
Laboratories, Ironwood,Ischemix, Lilly, Medtronic, Pfizer, Roche, Sanofi Aventis, 
The Medicines Company; Royalties: Elsevier (Editor, Cardiovascular Intervention: A 
Companion to Braunwald’s Heart Disease); Site Co-Investigator: Biotronik, Boston 
Scientific, St. Jude Medical (now Abbott); Trustee: American College of Cardiology; 
Unfunded Research: Flow Co, Merck, PLx Pharma, Takeda. MJR reports a personal 
fees from Medtronic, Inc.
Patient consent Obtained.
Provenance and peer review Not commissioned; internally peer reviewed.
data sharing statement No additional data are available.
open Access This is an Open Access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work 
is properly cited and the use is non-commercial. See: http:// creativecommons. org/ 
licenses/ by- nc/ 4. 0/
© Article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2018. All rights reserved. No commercial use is permitted unless otherwise 
expressly granted.
RefeRences
 1. Moat NE. Will tavr become the predominant method for treating 
severe aortic stenosis? N Engl J Med 2016;374:1682–3.
 2. Grover FL, Vemulapalli S, Carroll JD, et al. 2016 Annual report 
of The Society of Thoracic Surgeons/ American College of 
Cardiology transcatheter valve therapy registry. J Am Coll Cardiol 
2017;69:1215–30.
 3. Garcia D, Dumesnil JG, Durand LG, et al. Discrepancies between 
catheter and Doppler estimates of valve effective orifice area can 
be predicted from the pressure recovery phenomenon: practical 
implications with regard to quantification of aortic stenosis 
severity.  
J Am Coll Cardiol 2003;41:435–42.
 4. Hamm CW, Arsalan M, Mack MJ. The future of transcatheter aortic 
valve implantation. Eur Heart J 2016;37:803–10.
 5. Vasa-Nicotera M, Sinning JM, Chin D, et al. Impact of paravalvular 
leakage on outcome in patients after transcatheter aortic valve 
implantation. JACC Cardiovasc Interv 2012;5:858–65.
 6. Sinning JM, Hammerstingl C, Vasa-Nicotera M, et al. Aortic 
regurgitation index defines severity of peri-prosthetic regurgitation 
and predicts outcome in patients after transcatheter aortic valve 
implantation. J Am Coll Cardiol 2012;59:1134–41.
 7. Barbanti M, Yang TH, Rodès Cabau J, et al. Anatomical and 
procedural features associated with aortic root rupture during balloon-
expandable transcatheter aortic valve replacement. Circulation 
2013;128:244–53.
 8. Shenouda J, Silber D, Subramaniam M, et al. Evaluation 
and management of concomitant hypertrophic obstructive 
cardiomyopathy and valvular aortic stenosis. Curr Treat Options 
Cardiovasc Med 2016;18:17.
